Post-IPO Equity Aquilo Capital Management, an investment group owned by US investor Marc Schneidman, has invested in Pieris Pharmaceuticals. Aquilo was one of five investors committing $32 million to the […]
This is a Premium article. Please subscribe to continue reading.
